Ginkgo Bioworks Holdings, Inc. , which is building the leading platform for cell programming and biosecurity, today announced its results for the third quarter ended September ...
A study of Gila monster venom helped start the revolution in weight-loss drugs. But scientists think that’s just the ...
Its effectiveness in maintaining equipment cleanliness elevates its significance in various industrial settings. The role of ...
Just as in chemistry, these catalysts operate at multiple levels and can be combined into more sophisticated “molecular” ...
The United States Food and Drug Administration cleared the investigational new drug application for VLS-01 (buccal film DMT); ...
Phase 2b clinical trial (ELPIS II) evaluating Lomecel-B™ in rare pediatric disease HLHS has achieved more than 80% enrollmentPositive Type C ...
15h
Generated $50.0 million in net revenue from sales of LUMRYZ™ ----2,300 patients on LUMRYZ as of September 30th, including 700 patients that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback